Aybintio (abaloparatide)
Aybintio is a prescription medicine used to treat osteoporosis in postmenopausal women at high risk…
Risk of Hemolytic Disease of the Newborn (HDN) when an Rh-negative mother carries an Rh-positive fetus When an Rh-negative mother carries an Rh-positive fetus, there is a risk of hemolytic disease of the newborn (HDN) because the mother’s immune system may produce antibodies against the Rh antigen in the fetal blood, leading to the destruction…… Read More »
The management of blood group incompatibility during pregnancy requires close collaboration between obstetricians, maternal-fetal medicine specialists, neonatologists, and other healthcare providers to ensure optimal outcomes for both mother and baby…. Read More »
Some studies have suggested that lower levels of testosterone may be associated with an increased risk of colorectal cancer. One possible explanation for a link between low testosterone levels and colorectal cancer is that testosterone has anti-inflammatory properties and may help to reduce inflammation in the gut…. Read More »
Obesity is particularly problematic in terms of colorectal cancer risk when it is centralized around the abdomen (often referred to as “visceral obesity”) rather than being distributed more evenly throughout the body. Visceral obesity is associated with higher levels of inflammation and other metabolic abnormalities that may increase the risk of cancer…. Read More »